Concepedia

Publication | Closed Access

LBA17 ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC)

DOI

64

Citations

0

References

2020

Year

Aditya Bardia, Sara M. Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Hope S. Rugo, Adam Brufsky, Kevin Kalinsky, Javier Cortés, Joyce O’Shaughnessy,
Annals of Oncology

No additional data available for this publication yet. Check back later!